| Patents for G01N 33 - Investigating or analysing materials by specific methods not covered by groups (393,632) |
|---|
| 01/22/2009 | WO2009010121A1 Phosphorylation of histone h3 at threonine 11 - a novel epigenetic mark for transcriptional regulation |
| 01/22/2009 | WO2009009908A1 A recombmase based screening method for detecting molecular interactions comprising a single plasmid vector with two unique recombmase sites |
| 01/22/2009 | WO2009009899A1 Haemozoin detection |
| 01/22/2009 | WO2009009892A1 Engineered scfv against bovine herpes virus type i |
| 01/22/2009 | WO2009009890A1 Ovarian cancer biomarkers |
| 01/22/2009 | WO2009009883A1 An anti-cancer cytotoxic monoclonal antibody |
| 01/22/2009 | WO2009009882A1 An anti-cancer cytotoxic monoclonal antibody |
| 01/22/2009 | WO2009009881A1 An anti-cancer cytotoxic monoclonal antibody |
| 01/22/2009 | WO2009009848A1 Fuel identification system and method |
| 01/22/2009 | WO2009009843A1 Method for measuring biodiesel concentration in a biodiesel diesel oil mixture |
| 01/22/2009 | WO2008151110A3 Molecular diagnosis and typing of lung cancer variants |
| 01/22/2009 | WO2008143879A3 Vitamin e supplementation for reducing cardiovascular events in individuals with dm and the hp 2-2 genotype |
| 01/22/2009 | WO2008143722A3 Test device, method and kit for phage detection |
| 01/22/2009 | WO2008139049A3 Method for monitoring the co2 content in brines |
| 01/22/2009 | WO2008136996A3 Polymorphisms in genes affecting ace-related disorders and uses thereof |
| 01/22/2009 | WO2008133728A3 Sequential analysis of biological samples with intermediate bleaching of fluorescence detector |
| 01/22/2009 | WO2008133727A3 Sequential analysis of biological samples with bleaching of intermediate fluorescent signals |
| 01/22/2009 | WO2008131904A3 Device for detection of contents of a liquid in particular in raw expressed urine |
| 01/22/2009 | WO2008118970A3 Constructs and libraries comprising antibody surrogate light chain sequences |
| 01/22/2009 | WO2008109431A3 Constitutively open herg (kv11.1) mutant channels |
| 01/22/2009 | WO2008108794A3 Controlling dendritic cell maturation state in the lymphoid tissue equivalent of an artificial immune system |
| 01/22/2009 | WO2008103761A9 Methods and compositions for cancer diagnosis and treatment based on nucleic acid methylation |
| 01/22/2009 | WO2008082519A3 Screening for cd93 (c1qrp)-associated polymorphism(s) in the diagnosis, prevention and treatment of autoimmune diseases |
| 01/22/2009 | WO2008082436A3 Method for detecting pathogens |
| 01/22/2009 | WO2008073070A3 Antibodies to a spore specific glycosyl hydrolase |
| 01/22/2009 | WO2008070460A9 The use of soluble e-cadherin as a novel serum marker |
| 01/22/2009 | WO2008026075A3 Treatment of intracellular bacterial infections with a protein kinase inhibitor or an as160 polypeptide activator |
| 01/22/2009 | WO2007092855A9 Methods for resolving convoluted peaks in a chromatogram |
| 01/22/2009 | WO2007079229A3 Devices and methods for enrichment and alteration of circulating tumor cells and other particles |
| 01/22/2009 | WO2005010676A9 Methods and apparatus for investigating side effects |
| 01/22/2009 | WO2001092300A9 Chimeric gfp-aequorin as bioluminescent ca++ reporters at the single cell level |
| 01/22/2009 | US20090025098 Hepatitis C receptor protein CD81 |
| 01/22/2009 | US20090025096 P4has as modifiers of the igfr pathway and methods of use |
| 01/22/2009 | US20090025095 Method for Evaluating Compound Using Barlp and Substance for Regulating Eating and Body Weight |
| 01/22/2009 | US20090024333 Methods and systems relating to mitochondrial DNA phenotypes |
| 01/22/2009 | US20090024331 Methods and processes for calling bases in sequence by incorporation methods |
| 01/22/2009 | US20090024055 All-in-one biological specimen collecting, transporting and analyzing device |
| 01/22/2009 | US20090024019 Methods and apparatuses for detecting analytes in biological fluid of an animal |
| 01/22/2009 | US20090023928 Phthalamide-lanthanide complexes for use as luminescent markers |
| 01/22/2009 | US20090023910 Applications with and Methods for Producing Selected Interstrand Cross-Links in Nucleic Acids |
| 01/22/2009 | US20090023897 Method and apparatus for purifying and desalting biological samples |
| 01/22/2009 | US20090023794 Use of Sumoylation Inhibitors for the Treatment of Neurodegenerative Disease |
| 01/22/2009 | US20090023672 Age-2 aptamer |
| 01/22/2009 | US20090023662 recognize extracellular structures of G protein-coupled receptors; for treating humoral kidney rejection |
| 01/22/2009 | US20090023660 Novel Hemopoietin Receptor Protein, NR12 |
| 01/22/2009 | US20090023659 Using cell surface adhesion proteins specific immunoglobulin to target therapeutics to tumorous; immunodiagnostics; immunotherapy |
| 01/22/2009 | US20090023645 AIB1, a novel steroid receptor co-activator |
| 01/22/2009 | US20090023637 Methods for detecting and treating interstitial cystitis |
| 01/22/2009 | US20090023598 Method for extracting quantitative information relating to an influence on a cellular response |
| 01/22/2009 | US20090023592 System for identifying and analyzing expression of are-containing genes |
| 01/22/2009 | US20090023591 Cardiac hormones for assessing cardiovascular risk |
| 01/22/2009 | US20090023228 Dual-acting Imidazole antihypertensive agents |
| 01/22/2009 | US20090023227 Method |
| 01/22/2009 | US20090023226 Variant Integrin Polypeptides and Uses Thereof |
| 01/22/2009 | US20090023225 Using antibody adhesion and electrophoretic separation to recover preferential protein from solution |
| 01/22/2009 | US20090023224 Vascular endothelial growth factor 2 |
| 01/22/2009 | US20090023222 determines analyte concentration from an output signal generated by an oxidation/reduction reaction of the analyte; provide accurate and precise analyte concentrations at a reference temperature |
| 01/22/2009 | US20090023221 Oligonucleotide probes useful for detection and analysis of microrna precursors |
| 01/22/2009 | US20090023220 Method for discriminating between prostatic cancer and benign prostatic hyperplasia |
| 01/22/2009 | US20090023218 Test method for determining etch performance of coated substrate |
| 01/22/2009 | US20090023207 CHROMOSOME 3p21.3 GENES ARE TUMOR SUPPRESSORS |
| 01/22/2009 | US20090023200 Particle for detecting enzyme activity, method for detecting the enzyme activity and enzyme activity detection device by the use thereof |
| 01/22/2009 | US20090023173 Luminescence-based methods and probes for measuring cytochrome P450 activity |
| 01/22/2009 | US20090023170 Methods And Kits For The Detection of Biotoxic and Antibiotic Residues |
| 01/22/2009 | US20090023169 High throughput sarcomeric assay |
| 01/22/2009 | US20090023168 Method of screening placental proteins responsible for pathophysiology of preeclampsia, and marker for early diagnosis and prediction of preeclampsia |
| 01/22/2009 | US20090023166 Method For the in Vitro Diagnosis of Autoimmune Immune Response by Detection of Antibodies Directed Against The Pentraxin 3 Antigen |
| 01/22/2009 | US20090023165 Methods for Early Diagnosis of Kidney Disease |
| 01/22/2009 | US20090023164 Compositions and methods for the detection of hiv-1/hiv-2 infection |
| 01/22/2009 | US20090023163 Method of Measuring Enzyme Activity and Method of Evaluating Compound |
| 01/22/2009 | US20090023162 Method for the identification of atypical p-anca |
| 01/22/2009 | US20090023161 Structural basis for targeting hiv-1 gag proteins to the plasma membrane for virus assembly |
| 01/22/2009 | US20090023160 Antibodies specific for CYP1B1 |
| 01/22/2009 | US20090023159 Method for the in vitro diagnosis of alzheimer's disease using a monoclonal antibody |
| 01/22/2009 | US20090023158 Compositions and Methods for Identifying Substrate Specificity of Inhibitors of Gamma Secretase |
| 01/22/2009 | US20090023157 Proteome epitope tags and methods of use thereof in protein modification analysis |
| 01/22/2009 | US20090023156 Methods and reagents for quantifying analytes |
| 01/22/2009 | US20090023155 Polyelectrolyte multilayer films at liquid-liquid interfaces and methods for providing and using same |
| 01/22/2009 | US20090023154 Relating to marking |
| 01/22/2009 | US20090023152 Transcription factor MHC class II genes, substances capable of inhibiting this transcription factor and medical uses of these substances |
| 01/22/2009 | US20090023148 rapid, sensitive, and accurate method that can be used to measure nearly any analyte; employed to visualize the relationship between gene expression and tissue morphology |
| 01/22/2009 | US20090023147 Diagnostics and therapeutics for osteoporosis |
| 01/22/2009 | US20090023145 Methods of diagnosing or prognosing Alzheimer's disease |
| 01/22/2009 | US20090023144 Method and its kit for quantitatively detecting specific analyte with single capturing agent |
| 01/22/2009 | US20090023143 Predicting agent for metastasis |
| 01/22/2009 | US20090023138 Oral cancer markers and their detection |
| 01/22/2009 | US20090023135 Detection of enhanced multiplex signals by surface enhanced raman spectroscopy |
| 01/22/2009 | US20090023134 Neoplasia diagnostic compositions and methods of use |
| 01/22/2009 | US20090022825 Method for Predicting Whether Subjects With Mild Cognitive Impairment (MCI) Will Develop Alzheimer's Disease |
| 01/22/2009 | US20090022754 Construction of recombinant immunodominant Rickettsia typhi proteins; using methylated or unmethylated recombinant OmpB fragments in immunoassays for detection of exposure to Rickettsia typhi |
| 01/22/2009 | US20090022753 Surface proteins of streptococcus pyogenes |
| 01/22/2009 | US20090022745 Polypeptides and antibodies derived from chronic lymphocytic leukemia cells and uses thereof |
| 01/22/2009 | US20090022741 Targetting slow-growing, relatively mutationally-spared cancer; one-step genetic switches; antiproliferative agents; magnetic resonance imaging |
| 01/22/2009 | US20090022740 Targetting slow-growing, relatively mutationally-spared cancer; one-step genetic switches; antiproliferative agents; magnetic resonance imaging |
| 01/22/2009 | US20090022737 Aldos as modifiers of the igf pathway and methods of use |
| 01/22/2009 | US20090022736 Monoclonal Antibodies That Specifically Bind To And Neutralize Bacillus Anthracis Toxin, Compositions, And Methods Of Use |
| 01/22/2009 | US20090022724 Attractin/mahogany-like polypeptides, polynucleotides, antibodies and methods of use thereof |
| 01/22/2009 | US20090022722 Cytotoxicity mediation of cells evidencing surface expression of CD59 |
| 01/22/2009 | US20090022713 Anti-pro87299 antibodies |
| 01/22/2009 | US20090022711 Methods of modulating cell death based on the bit-1/aes regulatory pathway |